US Patent 8828401 Cytotoxic peptides and antibody drug conjugates thereof

Patent 8828401 was granted and assigned to Pfizer Limited on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8828401

Patent Inventor Names

Pavel Strop0

Russell George Dushin0

Andreas Maderna0

Beth Vetelino0

Chakrapani Subramanyam0

Christopher John O'Donnell0

Edmund Idris Graziani0

Matthew David Doroski0

Date of Patent

September 9, 2014

Patent Application Number

13670612

Date Filed

November 7, 2012

Patent Citations Received

‌

US Patent 11833216 Anti-EDB antibodies and antibody-drug conjugates

Patent Primary Examiner

‌

Karlheinz R. Skowronek

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8828401 Cytotoxic peptides and antibody drug conjugates thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API